Novartis AG NVS

145.46 2.75 1.93% as of 25 Sep
Market cap
$264.3B
P/E
21.8×
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
19.15 16.47 14.05 28.91 8.16 26.60 18.53 14.16 103.59 40.05
P/S ratio
4.72 3.80 4.50 4.63 3.71 4.31 4.46 3.87 0.00 0.00
P/FCF ratio
17.34 14.06 15.10 16.32 14.99 18.64 16.44 14.21 0.00 0.00
P/Operating CF
118.08 46.83 82.36 48.92 50.51 53.69 61.28 47.35 (26.12) (21.61)
P/B ratio
5.74 4.45 4.49 3.38 2.89 3.79 3.91 2.27 0.00 0.00
EV/Sales
5.10 4.11 4.71 4.79 3.73 4.80 4.78 4.22 (1.40) (1.25)
EV/EBITDA
12.62 12.11 16.53 13.97 16.86 18.01 18.77 19.02 0.00 0.00
EV/FCF
18.76 15.21 15.83 16.91 15.06 20.77 17.64 15.50 (6.62) (6.51)
Current Ratio
1.12 1.04 1.16 1.29 1.51 0.90 1.04 1.20 1.21 1.12
Net Debt/EBITDA
0.96 0.78 0.56 0.49 0.07 1.50 1.07 1.19 1.30 1.12
Debt/Equity
0.72 0.67 0.53 0.44 0.43 0.64 0.49 0.41 0.38 0.32
ROE
30.84% 26.28% 27.97% 10.93% 38.59% 14.39% 17.48% 16.49% 10.33% 8.83%
ROA
13.12% 11.81% 13.66% 5.58% 18.51% 6.56% 8.89% 9.05% 5.85% 5.13%
ROIC
16.10% 15.08% 10.72% 7.45% 10.64% 7.82% 7.94% 5.54% 5.78% 5.68%
Return on Tangible Assets
100.14% 114.05% 109.15% 36.57% 88.79% 90.93% 88.15% 58.24% 36.22% 36.55%
Average Days of Receivables
58.88 53.32 58.93 69.99 57.18 61.86 64.15 71.06 64.08 61.71
Earnings Yield
5.22% 6.07% 7.12% 3.46% 12.26% 3.76% 5.40% 7.06% 0.97% 2.50%
Free Cash Flow Yield
5.77% 7.11% 6.62% 6.13% 6.67% 5.36% 6.08% 7.04% (11.87%) (12.19%)
Free Cash Flow per Share
7.95 6.92 6.69 5.65 5.84 5.07 5.76 5.41 4.50 3.98
Book value per Share
24.01 21.87 22.51 27.25 30.24 24.89 24.25 33.93 31.64 31.49
Free Cash Flow
15,421.00 13,971.00 13,897.00 12,325.00 13,088.00 11,533.00 13,198.00 12,549.00 10,566.00 9,455.00
EV/EBIT
16.40 14.61 22.52 26.22 16.86 23.59 25.63 22.80 0.00 0.00
Other line items

Show all line items

Columns are period end dates